5 Best Biotech Penny Stocks To Buy Now

4. Atossa Genetics Inc. (NASDAQ:ATOS)

Number of Hedge Fund Holders: 8

Share Price as of November 29: $0.77

Atossa Genetics Inc. (NASDAQ:ATOS) works to discover and develop medicines in the areas of oncology and infectious diseases. The company is based in Seattle, Washington.

This November, Atossa Genetics Inc. (NASDAQ:ATOS) announced that it is acquiring an approximately 20% stake in Dynamic Cell Therapies to invest more in CAR-T therapy development. The company is making a $2 million cash payment to the privately-held company. The company’s EPS of -$0.06 in the third quarter was in line with estimates.

Eight hedge funds were long Atossa Genetics Inc. (NASDAQ:ATOS) in the third quarter. Their total stake value was $5.3 million.

Follow Atossa Therapeutics Inc. (NASDAQ:ATOS)